Vijay Shankar

Array ( [id] => 11082234 [patent_doc_number] => 20160279199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME' [patent_app_type] => utility [patent_app_number] => 15/059001 [patent_app_country] => US [patent_app_date] => 2016-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5726 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15059001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10799153 [patent_doc_number] => 20160145310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'HYPERSENSITIVE RESPONSE ELICITOR PEPTIDES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/016768 [patent_app_country] => US [patent_app_date] => 2016-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 34723 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15016768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13675151 [patent_doc_number] => 20160376309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => AROMATIC-CATIONIC PEPTIDES AND USES OF SAME [patent_app_type] => utility [patent_app_number] => 15/012286 [patent_app_country] => US [patent_app_date] => 2016-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15060 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16703190 [patent_doc_number] => 10953104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-23 [patent_title] => Dimeric collagen hybridizing peptides and methods of using [patent_app_type] => utility [patent_app_number] => 15/547504 [patent_app_country] => US [patent_app_date] => 2016-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 15144 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10791570 [patent_doc_number] => 20160137726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'SINGLE DOMAIN BINDING MOLECULE' [patent_app_type] => utility [patent_app_number] => 15/005463 [patent_app_country] => US [patent_app_date] => 2016-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13236 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15005463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11011029 [patent_doc_number] => 20160207979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 15/001078 [patent_app_country] => US [patent_app_date] => 2016-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 57730 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13425193 [patent_doc_number] => 20180264139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => COMPOSITION [patent_app_type] => utility [patent_app_number] => 15/537577 [patent_app_country] => US [patent_app_date] => 2015-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18869 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15537577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12584907 [patent_doc_number] => 20180086798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => NOVEL PI3K GAMMA INHIBITOR PEPTIDE FOR TREATMENT OF RESPIRATORY SYSTEM DISEASES [patent_app_type] => utility [patent_app_number] => 15/539339 [patent_app_country] => US [patent_app_date] => 2015-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14975503 [patent_doc_number] => 10441638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-15 [patent_title] => Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis [patent_app_type] => utility [patent_app_number] => 15/535020 [patent_app_country] => US [patent_app_date] => 2015-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 7901 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13867569 [patent_doc_number] => 20190030125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => USE OF FIBULIN-5 FOR THE TREATMENT OF KELOID SCARS [patent_app_type] => utility [patent_app_number] => 15/533691 [patent_app_country] => US [patent_app_date] => 2015-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9467 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14422541 [patent_doc_number] => 10316060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Energy transfer within pi-conjugated peptide heterostructures in aqueous environments [patent_app_type] => utility [patent_app_number] => 14/950603 [patent_app_country] => US [patent_app_date] => 2015-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 172 [patent_no_of_words] => 30552 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14950603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11895194 [patent_doc_number] => 09765119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Cyclosporine analogue mixtures and their use as immunomodulating agents' [patent_app_type] => utility [patent_app_number] => 14/949616 [patent_app_country] => US [patent_app_date] => 2015-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 25257 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14949616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13867547 [patent_doc_number] => 20190030114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => ISOFORM-SPECIFIC CALPAIN INHIBITORS, METHODS OF IDENTIFICATION, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/525849 [patent_app_country] => US [patent_app_date] => 2015-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10769056 [patent_doc_number] => 20160115212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'TUMOR-ASSOCIATED PEPTIDES BINDING PROMISCUOUSLY TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS II MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/933077 [patent_app_country] => US [patent_app_date] => 2015-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23326 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14933077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10774779 [patent_doc_number] => 20160120936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'METHODS OF PREVENTING SURGICAL SITE INFECTIONS' [patent_app_type] => utility [patent_app_number] => 14/928281 [patent_app_country] => US [patent_app_date] => 2015-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6706 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14928281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12051212 [patent_doc_number] => 20170327557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'Efficient delivery of therapeutic molecules to cells of the inner ear' [patent_app_type] => utility [patent_app_number] => 15/523317 [patent_app_country] => US [patent_app_date] => 2015-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33465 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14977867 [patent_doc_number] => 10442834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-15 [patent_title] => Deprotection method [patent_app_type] => utility [patent_app_number] => 14/873517 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5983 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16244220 [patent_doc_number] => 10743538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Elicitor peptides having disrupted hypersensitive response box and use thereof [patent_app_type] => utility [patent_app_number] => 14/872347 [patent_app_country] => US [patent_app_date] => 2015-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28290 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16490531 [patent_doc_number] => 10856546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Hypersensitive response elicitor peptides and use thereof [patent_app_type] => utility [patent_app_number] => 14/872298 [patent_app_country] => US [patent_app_date] => 2015-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 32548 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16490531 [patent_doc_number] => 10856546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Hypersensitive response elicitor peptides and use thereof [patent_app_type] => utility [patent_app_number] => 14/872298 [patent_app_country] => US [patent_app_date] => 2015-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 32548 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872298 [rel_patent_id] =>[rel_patent_doc_number] =>)